RespireRx Pharmaceuticals Inc (RSPI)

[LTListener]

"Clearly one of the big pharmas woukd have the existing infrastructurestructure to bring the multiple drugs' efficacy to market sooner than later = win/win for all concerned"

Exactly. Thinking out loud. They have the OSA pipeline transferred to Australia for development and listing. Which no recent update and no reflection of the value in the market cap. They recently stated they want to do more clinicals on the SCI/ADHD drug, but maybe later, pending financing....

This leaves the KRM-II-81 for pain and epilepsy. They continually seem enthusiastic and optimistic about this drug and it has advanced to presumably final preclinical stages in the NIH program. Considering the unmet pharma needs and public awareness of opioid crisis, it is going to take a large pharma with all encompassing infrastructure/resources to push this. On the surface, it would seem this preclinical drug would have tremendous value now, but even moreso if the NIH program green lights it into human clinicals!